POSTER SESSION I

STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION
Monday, March 9, 2009   —  9:30 AM - 12:00 Noon
Hynes Convention Center, Hall C/D


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




BREAST PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
21 Automatic Detection of Micrometastases in Lymph Nodes by Infrared Micro-Spectral Imaging (111)
H Ashby-Richardson, NM Laver, SP Naber, BL Bird, M Diem - Tufts Medical Center, Boston, MA; Northeastern University, Boston, MA
Add
22 Epithelial Cell Adhesion Molecule Is Overexpressed in Breast Cancer Metastases Compared to Matched Primary Cancers (140)
A Cimino, M Halushka, P Illei, D Molavi, X Wu, S Sukumar, P Argani - The Johns Hopkins Hospital, Baltimore, MD
Add
23 Relationship between Molecular Phenotype of Invasive Breast Cancer and Expression of Androgen Receptor (141)
K Cole, R Tamimi, R Hu, G Colditz, S Schnitt, L Collins - Beth Israel Deaconess Medical Center, Harvard Medical School; Harvard School of Public Health; and Brigham and Women's Hospital, Boston, MA; Washington Univ. School of Medicine, St. Louis, MO
Add
24 Benign Breast Biopsies in Women That Later Developed Carcinoma: Distinctive Histologic Features and Stem Cell Marker Expression (147)
C Cookingham, K Toy, CG Kleer - University of Michigan, Ann Arbor, MI
Add
25 Pathologic Response and Microvascular Surface Area in Breast Cancer Treated with Neoadjuvant Chemotherapy (148)
AD Corben, R Abi-Raad, R Boutrus, DC Sgroi, A Taghian, EF Brachtel - Massachusetts General Hospital, Boston, MA
Add
26 Predictive Markers (ER, PR, HER2, HER2FISH) Pre- and Post-Neoadjuvant Chemotherapy in Primary Breast Carcinoma (150)
MD Darrow, C Cohen, A Nassar - Emory University, Atlanta, GA; The Mayo Clinic, Rochester, MN
Add
27 "Modified" Alcian Blue Enhances the Intraoperative Diagnosis of Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma: A Prospective Study (164)
C Fan, D Malik, S Kulkartni, N Daoud, D Tan, T Khoury - Roswell Park Cancer Institute, Buffalo, NY; MD Anderson, Houston, TX
Add
28 Ductal Carcinoma In Situ in Women under Age of 35 (172)
J Gao, ME Sullivan, SA Khan, B Susnik - Northwestern University Feinberg School of Medicine, Chicago, IL
Add
29 Microarray CGH Analysis Reveals Genetic Heterogeneity between Distinct Components of Metaplastic Breast Carcinomas (175)
FC Geyer, D de Biase, B Weigelt, MBK Lambros, A Mackay, K Fenwick, N Tamber, A Ashworth, JS Reis-Filho - ICR, London, United Kingdom; Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley
Add
30 Detailed FISH Analysis of HER2 2+ Immunohistochemistry Cases: Rarity of Cases with High Level HER2 Gene Amplification (179)
DC Gingell, DJ Dabbs, U Surti, R Bhargava - Magee-Womens Hospital of UPMC, Pittsburgh, PA
Add
31 Validation of Dako DuoCISH™ HER2 Gene Amplification Assay (182)
NA Granger, CM Haynes, A Quinn, X Wang, P Tang, L McMahon, H Yaziji, D Hicks, LM Schiffhauer - University of Rochester, Rochester, NY; Vitro Molecular Laboratories, Miami, FL; SUNY Syracuse, Syracuse, NY; Stanford University, Stanford, CA
Add
32 Can ER and CK5 Identify Atypical Epithelial Proliferations in Papillary Lesions of the Breast on Core Biopsy? (184)
AN Grin, FP O'Malley, AM Mulligan - University of Toronto Mount Sinai Hospital; AND St. Michael's Hospital, Toronto, ON, Canada
Add
33 Comparative Analysis of p53 Expression in Triple Negative Versus Non-Triple Negative Invasive Breast Cancers (192)
JS Han, KH Molberg, V Sarode, AV Gavino, Y Peng - UT Southwestern, Dallas, TX
Add
34 Positive HER2 Immunoreactivity in DCIS Is Associated with a Higher Incidence of Invasive Disease, Particularly in the Subsequent Resection in a Group of Patients without Radiographic Evidence of Invasion Disease (194)
S Harada, R Roses, HL Niu, S Weinstern, H Nisenbaum, KR Fox, BJ Czerniecki, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia, PA
Add
35 Expression of Estrogen Receptor β and BRCA1 in Male and Female Breast Cancer (220)
TS Kraus, C Cohen - Emory University, Atlanta, GA
Add
36 Utility of Frozen Section for Intra-Operative Evaluation of Sentinel Lymph Nodes in Breast Cancer (224)
UR Kundu, KK Hunt, S Krishnamurthy - MD Anderson Cancer Center, Houston, TX
Add
37 Metaplastic Sarcomatoid Carcinoma of the Breast: Poor Overall Survival Is Independent of the Amount of Sarcomatoid Component (231)
TR Lester, KM Nayeemuddin, WG Davis, KK Hunt, MZ Gilcrease - The University of Texas M.D. Anderson Cancer Center, Houston, TX
Add
38 Breast Carcinoma and Lobule Development in Males: 5 Year Review at the Ottawa Hospital (241)
M Marinescu, IT Ahmed, S Roberson - The Ottawa Hospital, The University of Ottawa, Ottawa, ON, Canada
Add
39 Objective Assessment of Lymphatic and Blood Vascular Invasion in Breast Carcinoma: Findings from a Large Case Series with Long Term Follow up (246)
RA Mohammed, SG Martin, AM Mahmmod, EC Paish, IO Ellis - School of Molecular Medical Sciences-University of Nottingham, Nottingham, United Kingdom; Faculty of Medicine-Assiut University, Assiut, Egypt
Add
40 Y-Box-Binding Protein-1 Expression Is Associated with Suppressed E-Cadherin Levels and Poor Prognosis in Breast Cancer (256)
T Ng, V Evdokimova, N Melnyk, P Sorensen - BC Cancer Research Centre and University of British Columbia, Vancouver, BC, Canada
Add
41 Pleomorphic Carcinoma of the Breast: Is Severe Pleomorphism Associated with a Worse Clinical Outcome? (257)
CV Nguyen, KK Hunt, KM Nayeemuddin, TR Lester, R Falcon-Escobedo, MZ Gilcrease - University of Texas M.D. Anderson Cancer Center, Houston, TX; and Medical School, Autonomous University of San Luis Potosi, San Luis Potosi, Mexico
Add
42 Androgen Receptor Expression in Breast Cancer Molecular Classes: An Immunohistochemical Study of 190 Consecutive Cases (259)
LA Niemeier, DJ Dabbs, JM Striebel, R Bhargava - University of Pittsburgh Medical Center, Pittsburgh, PA
Add
43 Mucocele-Like Lesions Diagnosed by Core Needle Biopsy of the Breast: Correlation with Surgical Excision (272)
DGK Phillips, CJ Sailey, J Warner, OB Ioffe - Univ of MD, Baltimore, MD
Add
44 Breast Cancer Incidence: A Possible Relationship to Folic Acid Fortification? (276)
P Reddy, M Hogarth, C-S Li, JW Miller, R Green -University of California, Davis, Sacramento, CA
Add
45 Evaluation of the Predictive Ability of a CK5/p63/CK8/18 Antibody Cocktail in Stratifying Breast Papillary Lesions on Needle Biopsy: An Algorithmic Approach Works Best (278)
ES Reisenbichler, AL Adams, O Hameed - University of Alabama School of Medicine, Birmingham, AL
Add
46 Columnar Cell Lesions Diagnosed by Core Needle Biopsy of the Breast: Correlation with Surgical Excision (284)
CJ Sailey, DGK Phillips, J Warner, OB Ioffe - Univ of Maryland, Baltimore, MD
Add
47 Tumor Proteomic Profiling Predicts the Resistance of Breast Cancer to Chemotherapy (291)
D Shen, J He, DU Cheung, KF Faull, JP Whitelegge, RE Saxton, HR Chang - UCLA David Geffen School of Medicine and USC Keck School of Medicine, Los Angeles, CA
Add
48 Isolated Tumor Cells and/or Micrometastasis in Breast Sentinel Lymph Nodes Can Be the Result of Innocuous Passive Dissemination (293)
BB Shetuni, S Simpson, K Yearsley, Y Xiao, SH Barsky - The Ohio State University College of Medicine, Columbus, OH
Add
49 Use of the Veridex GeneSearch™ BLN Assay in Clinical Practice To Evaluate Breast Sentinel Lymph Nodes (295)
N Sidiropoulos, LJ Tafe, MC Schwab, EJ Rizzo, SN Schutz, SH Boyle, PP Seery, WA Wells, GJ Tsongalis - Dartmouth Medical School, Dartmouth Hitchcock Medical Center, and Norris Cotton Cancer Center, Lebanon, NH
Add
50 Human Epididymis Protein 4 Expression Loss in Invasive Mammary Carcinoma Is Associated with Aggressive Disease and Adverse Clinical Outcome (300)
EA Slodkowska, CE Sheehan, AB Boguniewicz, CB Sheehan, C Chen, JS Ross - Albany Medical College, Albany, NY
Add
51 Indoleamine 2,3-Dioxygenase Expression in Invasive Breast Carcinoma Is Associated with Longer Relapse-Free Survival (304)
MR Steciuk, JD Pfeifer, MA Watson, O Hameed - University of Alabama at Birmingham, Birmingham, AL; Washington University, St. Louis, MO
Add
52 Bcl-2 Is Infrequently Upregulated in Metastatic Breast Carcinomas (306)
AP Subhawong, DW Molavi, MK Halushka, H Nassar, R Vang, S Sukumar, P Argani - The Johns Hopkins Hospital, Baltimore, MD
Add
53 Comparison of Gene Expression Profiles of Areas of Micropapillary Differentiation of Invasive Breast Carcinomas with Focal MP features with Usual Ductal (No Special Type) Components (318)
MJ Wagoner, G Paragh, Z Rakosy, M Ghayouri, G Acs - University of South Florida College of Medicine, Tampa, FL; Moffitt Cancer Center, Tampa, FL
Add
54 Expression of Insulin-Like Growth Factor-I Receptor in Normal Breast Tissue and Breast Cancer Risk: Results from the Nurses' Health Study (320)
Y Wang, J Connolly, R Hu, H Baer, G Colditz, S Schnitt, L Collins, R Tamimi - Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Harvard School of Public Health; and Harvard Medical School, Boston, MA; Washington University School of Medicine, St. Louis, MO
Add
55 Estrogen/Progesterone Receptor and HER2 Expression Profiles in Breast Cancers with Isolated Bone Metastasis Are Different from Those in BCs with Metastasis to Other Sites (321)
S Wei, O Hameed - University of Alabama School of Medicine, Birmingham, AL
Add
56 Does Nottingham Grade, MIB-1 Labeling Index Predict Recurrence Score of Oncotype Dx™ Assay? (333)
Z Zhang, R Shamanna, U Raju, A Ormsby, D Chitale - Henry Ford Hospital, Detroit, MI
Add